Translated with AI On April 20, 2026, Revision 1 of the MDCG 2021-24 guidance was published. This update introduces significant interpretative [...]
Translated with AI. On 1 April 2026, the European Commission published the Article 10a Decision Tree and Revision 2 of the [...]
Translated with AIOn April 1, 2026, Health Canada published the “Guidance on terms and conditions for class II to IV Medical [...]
Translated with AI On March 20, 2026, the European Commission adopted two delegated regulations, C (2026) 1809 and C (2026) 1798, [...]
Translated with AI In February 2026, the Medical Device Authority (MDA) published the 7th edition of the guidance document "Requirements for [...]
Translated with AIIn February 2026, the Australian Therapeutic Goods Administration (TGA) published version 2.0 of the official guide: "Complying with the [...]
On February 2, 2026, version 010 of the MDSAP AU P0002 – Audit Approach manual was released. This update comes nearly [...]
On February 2, 2026, the U.S. Food and Drug Administration issued the Compliance Program Manual 7382.850. The comprehensive document serves as [...]
On 26 January 2026, the Ministry of Health and Welfare (MOHW) and the Ministry of Food and Drug Safety (MFDS) launched [...]
Translated with AI The regulatory framework for medical device labelling in Thailand reached a comprehensive synthesis with the publication of the [...]
Thema srl
Via Saragat, 5
40026 Imola (BO) – Italy
Tel. +39 0542 643496
Fax. +39 0542 641833
info@complifegroup.com
Thema Corp
B+Labs c/o Cira Center
2929 Arch Street, Floor 4
Philadelphia, PA 19104 – U.S.A.
Tel. +1 215-845-9459
© Copyright Thema srl – 2024 | | All Rights Reserved – C.F./P.IVA IT02770361208 N. REA BO n.466056 | Cap. Soc.€ 50.000 i.v.
